Fact Check: Dr. Oz Will NOT Profit From iHerb When Trump FDA Recommends Folinic Acid For Treatment Of Autism - Oz Sold Shares, Resigned Paid Post

Fact Check

  • by: Dean Miller
Fact Check: Dr. Oz Will NOT Profit From iHerb When Trump FDA Recommends Folinic Acid For Treatment Of Autism - Oz Sold Shares, Resigned Paid Post Divesting

Would Dr. Mehmet Oz, a former diet supplement company advisor and investor, profit from the Trump Administration's plan to recommend folinic acid for those on the autism spectrum? No, that's not true: As a condition of taking the job of Administrator of the Center for Medicare and Medicaid Services, Oz pledged in writing to close out by July 3, 2025 his stake in iHerb, an LLC that sells folinic acid supplements. Even if he had not done so, the Department of Health and Human Services said it is only recommending prescription forms of folinic acid, not the direct-to-consumer products sold by marketers like iHerb.

The claim appeared in a September 22, 2025 X post (archived here) on the @simonmaechling account, which reads as follows:

RFK Jr is set to announce Tylenol causes autism. And then he'll push the "cure": leucovorin (folinic acid).
Who sells folinic acid? Dr. Oz's supplement company, iHerb. The same Dr. Oz who is now the Administrator of the Centers for Medicare & Medicaid Services (CMS) in Trump's administration.
Think about that: A government health official tied to the very supplement company that benefits from RFK Jr's bogus "cure." This isn't public health. It's corruption dressed up as wellness.

Here's what the post looked like on X at the time this fact check was written:

FolinicThumbnail.jpg

(Image source: Lead Stories screenshot of the post at x.com/simonmaechling.)

The Department of Health and Human Services took to X (archived here) to push back on the claim, noting that FDA guidance recommends only prescription drug and not the over-the-counter folinic acid supplements sold by companies like iHealth:

HHSLeucovorinPost.jpg

(Image source: Lead Stories screenshot of post at x.com/HHSGov.)

In a September 23, 2025 email to Lead Stories, iHerb Director of Global Communications Daphne Avila said Oz has cut his financial ties to the supplement maker:

Dr. Oz is no longer affiliated with iHerb as a result of a termination agreement executed earlier this year.

Therefore, he is not a paid advisor, officer or employee. He is divested from the company.

She made the same distinction made by the HHS X post, between diet supplement folinic acid and the prescription form, leucovorin:

OTC folinic acid supplements are typically in micrograms (mcg) and regulated as dietary supplements;

prescription leucovorin is milligram (mg) dosing and medically supervised.

They are not interchangeable.

Avila's email confirms the divestment pledge Oz made while being vetted for his job in the Trump Administration. He filed multiple signed public statements declaring he would divest and step away from iHerb and other healthcare industry companies that could benefit from his decisions as Administrator of the Centers for Medicare & Medicaid Services (CMS).

In a February 26, 2025 letter to the Office of Government Ethics, (archived here) Oz declared that upon confirmation as Administrator of CMS, he would resign from his roles at iHerb:

I only have a position with iHerb Oz Partners LLC ... Upon confirmation, I will resign from my position with iHerb Oz Partners LLC.

... for a period of one year after my resignation, I will not participate personally and substantially in any particular matter involving specific parties in which I know iHerb Oz Partners LLC is a party or represents a party ...

Oz, in the same letter, said that within 90 days of his (April 3, 2025) confirmation, he would forfeit unvested shares (RSUs) in the company, shed his vested shares and not participate in CMS decisions with a direct effect on iHerb:

Upon confirmation, I will resign as advisor to iHerb, LLC, a nutritional supplement company.

I will forfeit my unvested RSUs upon my resignation from iHerb, LLC. I also will divest my vested RSUs in iHerb, LLC as soon as practicable but not later than 90 days after
confirmation. I will not participate personally and substantially in any particular matter that to my knowledge has a direct and predictable effect on the financial interests of this entity until I
have divested it ... for a period of one year after my resignation, I will not participate personally and substantially in any particular matter involving specific parties in which I know iHerb, LLC is a party or represents a party ...

Avila declined to disclose what share of overall iHerb revenues is generated by folinic acid supplements.

Using search words in Google Shopping to narrow results to mostly folinic acid products, Lead Stories found (archived here) iHerb is one of a dozen companies selling the supplement, as seen in these screenshots:

FolinicProducts.jpg

(Image source: Lead Stories screenshots from search results at www.google.com/shopping.)

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:


  Dean Miller

Lead Stories Managing Editor Dean Miller has edited daily and weekly newspapers, worked as a reporter for more than a decade and is co-author of two non-fiction books. After a Harvard Nieman Fellowship, he served as Director of Stony Brook University's Center for News Literacy for six years, then as Senior Vice President/Content at Connecticut Public Broadcasting. Most recently, he wrote the twice-weekly "Save the Free Press" column for The Seattle Times. 

Read more about or contact Dean Miller

About Us

EFCSN International Fact-Checking Organization

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


WhatsApp Tipline

Have a tip or a question? Chat with our friendly robots on WhatsApp!

Add our number +1 (404) 655-4223, follow this link or scan the image below with your phone:

@leadstories

Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion